Introducing Galleri multi-cancer early detection test

Galleri is a proactive blood test that can be done annually, screening for many aggressive cancers before symptoms appear.1,2,3

Already Have An Account? Log in

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Roger testimonial

Patient Story: Roger, Cancer Signal Detected with the Galleri test

Patient Story: Roger, Cancer Signal Detected with the Galleri test

Already Have An Account? Log in

Galleri is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Who is eligible?

The Galleri test is available at no cost to eligible employees and dependents aged 50 and above on a BCBS medical plan.

Employees4

  • On a BCBS medical plan
  • 50 years and older
woman with brown hair wearing a tan sweater and gray pants smiling softly and sitting on a chair in her living room

Dependents / spouses4

  • On a BCBS medical plan
  • 50 years and older
Black couple sitting at their kitchen table writing on a notepad with a cup of coffee and a tablet on the table in front of them

While individuals ages 40-49 with certain risk factors may be at an elevated risk for cancer, Galleri was only studied in a population age 50 and older.5

Our testing process

illustrated graphic of a Black male doctor in a white lab coat reading a chart

Request the test

It will take about 10 minutes. Use your employer Insurance information to start an online health questionnaire about your medical history. Galleri is available by prescription only. By requesting the test and completing the questionnaire, you're requesting a prescription from Recuro Health, an independent telemedicine provider.

illustrated graphic of the Galleri test box sitting on a table in front of a window

Receive a collection kit

If the Recuro Health telemedicine provider confirms your eligibility and prescribes Galleri, you will receive a notification via email and a collection kit in the mail. Visit Galleri.com/schedule to book your blood draw appointment at a GRAIL blood draw partner.

illustrated graphic of a white, gray haired female patient having her blood drawn

Provide your sample

Bring your test kit and Test Requisition Form (TRF) with you to the appointment. A trained technician will draw your blood sample and ship the kit to the GRAIL lab.

Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

Receive your results

Recuro Health will contact you when your results are ready - about 2 weeks after your blood is received at the GRAIL laboratory.

The Galleri test is available at no cost to eligible employees and dependents aged 50 and above on a BCBS medical plan.

To access the Galleri test as a covered benefit, you must request the test through this webpage. 

When requesting through this website, an independent telemedicine healthcare provider will review your request and order the test if appropriate. The test is available by prescription only.

The cost of the Galleri test, blood draw, and laboratory fees are all covered under this benefit to eligible employees and dependents.

An at-home or in-lab blood draw is included in the price of the test if scheduled with one of our partner labs. Find a time and location convenient for you at Galleri.com/schedule.

Please have your BCBS medical ID card ready.

  • Enter your Name, Group Number, and Member ID Number exactly as they appear on your BCBS medical ID card.
  • If your Group ID does not appear in the drop-down menu, you are not eligible for the Galleri benefit through your medical plan. Call (833) 694‑2553 if you have questions or wish to order the test and make alternate payment arrangements.

Under this program employees and eligible dependents for the Galleri test will be able to complete the Galleri test every year.

To access the Galleri test as a covered benefit, you must request the test through this web page. An independent telemedicine provider will review your request and order the test, if appropriate.

The Galleri test is provided at no cost to eligible employees and dependents only when obtained through this authorized site https://www.Galleri.com/LSC.

The blood draw associated with Galleri must occur on a date you are covered under this employee benefit.

Employees are responsible for the full cost of the test when obtained via any other means such as a personal physician or when the blood draw date of service occurs after your benefit coverage has ended.

Get support

For questions about the Galleri test, please contact GRAIL Customer Service:

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes

  1. US Preventive Services Task Force. A,B,C grade recommendations, cancer, screenings. [cited 2023 Oct 23]. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results
  2. American Cancer Society Cancer Facts and Figures 2023. Available at: https://www.cancer.org/content/... GRAIL, Inc. Data on file GA-2021-0065
  3. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806
  4. Christine Clark Dur, Margaret McCusker. Evaluation of factors associated with elevated cancer risk among persons under age 50. GRAIL, LLC. Data on File GR-2023-0098
  5. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:10.1016/S0140-6736(23)01700-2